FDA RECOMMENDS ATTAPULGITE STUDY ENDPOINTS INCLUDE PATIENT GLOBAL ASSESSMENTS
This article was originally published in The Tan Sheet
Executive Summary
FDA RECOMMENDS ATTAPULGITE STUDY ENDPOINTS INCLUDE PATIENT GLOBAL ASSESSMENTS and time to last unformed stool at a Jan. 25 OTC feedback meeting with representatives from the Nonprescription Drug Manufacturers Association, Upjohn and Wyeth-Ayerst. Attapulgite is the active ingredient in Wyeth-Ayerst's Donnagel and Upjohn's Kaopectate antidiarrheal products.